lobbying_filings_raw: 0780de4e-6d8e-40f4-9f17-eea2e9da7c0e
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0780de4e-6d8e-40f4-9f17-eea2e9da7c0e | Q2 | 41454 | WILLIAMS AND JENSEN, PLLC | 151200 | ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) | 2016 | second_quarter | 2016-07-12T14:09:09.073000-04:00 | 50000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/0780de4e-6d8e-40f4-9f17-eea2e9da7c0e/", "filing_uuid": "0780de4e-6d8e-40f4-9f17-eea2e9da7c0e", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2016, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/0780de4e-6d8e-40f4-9f17-eea2e9da7c0e/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "TJ Hartten", "dt_posted": "2016-07-12T14:09:09.073000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "701 8th Street, NW", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 41454, "url": "https://lda.senate.gov/api/v1/registrants/41454/", "house_registrant_id": 30771, "name": "WILLIAMS AND JENSEN, PLLC", "description": "Lobbying Law Firm", "address_1": "1201 Pennsylvania Avenue, NW", "address_2": "Suite 800", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ISABELLA QUINN", "contact_telephone": "+1 202-659-8201", "dt_updated": "2026-01-30T10:10:58.206597-05:00"}, "client": {"id": 151200, "url": "https://lda.senate.gov/api/v1/clients/151200/", "client_id": 924, "name": "ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)", "general_description": null, "client_government_entity": false, "client_self_select": null, "state": "DE", "state_display": "Delaware", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-14"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 18077, "prefix": null, "prefix_display": null, "first_name": "GEORGE", "nickname": null, "middle_name": null, "last_name": "OLSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 14682, "prefix": null, "prefix_display": null, "first_name": "SUSAN", "nickname": null, "middle_name": null, "last_name": "HIRSCHMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 48784, "prefix": "mr", "prefix_display": "MR.", "first_name": "MATTHEW", "nickname": null, "middle_name": "B", "last_name": "HOEKSTRA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65303, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": "BOOK", "last_name": "MULLEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 43395, "prefix": "ms", "prefix_display": "MS.", "first_name": "MELINDA", "nickname": null, "middle_name": "M", "last_name": "MAXFIELD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 61426, "prefix": null, "prefix_display": null, "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 10, "name": "Vice President of the U.S."}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Tax issues affecting the pharmaceutical industry, tax reform issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 18077, "prefix": null, "prefix_display": null, "first_name": "GEORGE", "nickname": null, "middle_name": null, "last_name": "OLSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 10, "name": "Vice President of the U.S."}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 18077, "prefix": null, "prefix_display": null, "first_name": "GEORGE", "nickname": null, "middle_name": null, "last_name": "OLSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65303, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": "BOOK", "last_name": "MULLEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 15838, "prefix": "mr", "prefix_display": "MR.", "first_name": "JACK", "nickname": null, "middle_name": "STEVEN", "last_name": "HART", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 14682, "prefix": null, "prefix_display": null, "first_name": "SUSAN", "nickname": null, "middle_name": null, "last_name": "HIRSCHMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 48784, "prefix": "mr", "prefix_display": "MR.", "first_name": "MATTHEW", "nickname": null, "middle_name": "B", "last_name": "HOEKSTRA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 61426, "prefix": null, "prefix_display": null, "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 10, "name": "Vice President of the U.S."}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |